Background: Obesity is associated with increased risk of cardiovascular disease. We investigated vasoreactivity in conduit and resistance arteries in morbidly obese subjects, and the effect of weight loss after gastric bypass surgery. Methods: A total of 19 obese subjects (body mass index (BMI): 43.8 ± 3.1 kg m À2 , 75% female, mean age 41 years) were investigated before surgery and after 1 and 12 months of surgery. Nineteen non-obese controls matched for age and gender were examined. Vasoreactivity was evaluated by ultrasound to measure flow-mediated dilation (FMD, evaluating a conduit vessel) and pulse-wave analysis with terbutaline provocation (change in reflectance index (RI), evaluating resistance vessels). Results: Before surgery, the obese showed a low change in RI (18 ± 12 vs 37 ± 15% in controls, P ¼ 0.0001), but not significantly regarding FMD (7.9 ± 6.4 vs 8.9 ± 5.4% in controls). Surgery resulted in a weight loss of 9% at 1 month and 30% at 1 year. Change in RI markedly improved to 36 ± 12% at 1 month (P ¼ 0.0001 vs baseline) and further to 44 ± 11% at 1 year (P ¼ 0.014 vs 1 month). FMD did not change significantly. Heart rate and brachial artery diameter were reduced, with no significant change in blood pressure. The improvement in resistance vessel vasodilation, estimated as change in RI, was not correlated to changes in weight or measures of glucose and lipid metabolism. Conclusions: Obese patients showed impaired vasoreactivity in resistance arteries that was normalized already 1 month after gastric bypass surgery. The basis for this remarkable outcome, not significantly related to changes in body weight and metabolic variables, remains to be clarified.
Introduction
Morbid obesity is associated with a shortened life span, mainly due to cardiovascular disorders. 1 Weight loss regimens, including pharmacological treatments, are most often not efficacious in the long run, whereas gastric bypass (GBP) surgery is associated with a pronounced weight loss that is maintained over long time periods. 2 During the last two decades, much attention has been paid to the function of the endothelium, 3 in particular as endothelial dysfunction has been shown to predict cardiovascular events. 4, 5 Two different methods to assess endothelium-dependent vasodilation are widely used in clinical research; the invasive forearm model using acetylcholine infusion in the brachial artery mainly assessing function in resistance arteries, and the brachial artery ultrasound technique using hyperemia to induce flow-mediated dilation (FMD) to evaluate function in the brachial conduit artery. Both of these techniques are related to the major cardiovascular risk factors, [6] [7] [8] [9] [10] but the techniques in themselves are not closely related at the individual level. [11] [12] [13] A noninvasive technique based on resistance vessel vasodilation induced by b-2 agonist administration and pulse-wave analysis has recently been validated by different groups, [14] [15] [16] with the invasive forearm model using acetylcholine infusion in the brachial artery. 12, 13 Although different studies in the past have linked obesity to endothelial dysfunction, [17] [18] [19] [20] [21] [22] there is limited data on the effect of weight loss on vasoreactivity. Park and Shim 17 reported an improvement in endothelium-dependent vasodilation, using the noninvasive pulse-wave-based method, following a weight reduction of 8 kg during a 12-week weight-loss program in premenopausal women. Williams et al., 23 as well as Gokce et al., 24 showed that FMD was improved after bariatric surgery, 23, 24 and similar findings were recently reported by Pontiroli et al. 25 We have recently shown that vasoreactivity measured in the brachial artery and in resistance vessels to be unrelated, [11] [12] [13] but both were related to coronary risk in the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. 13 Thus, we conducted this study with the aim to investigate both the short-term (1 month) and long-term (1 year) effect of weight loss induced by bariatric surgery ad modum GBP on vasoreactivity both in a conduit artery and in resistance vessels, with the hypothesis that vasoreactivity in both types of vessels would improve following weight loss after GBP surgery. To investigate vasoreactivity at baseline, we also included a non-obese age-and gender-matched control group.
Materials and methods

Participants
A total of 19 patients were recruited from the outpatient clinic for obesity care (University Hospital, Uppsala, Sweden), where pre-evaluations before and long-term checkup visits of patients after surgery were performed. A total of 19 age-and sex-matched non-obese controls were locally recruited (Table 1 ). All subjects were Caucasians and gave informed consent. The study was approved by the Regional Ethics Review Board of Uppsala University (Sweden).
GBP surgery
All patients had undergone standard Roux-en-Y GBP surgery. 26 In short, we divided the first gastric vessel on the lesser curvature, just below the fat pad, to create a small gastric pouch (2 Â 3 cm). The stapling was made very close to the wall of the stomach, taking care not to damage the nerve-vessel bundle (containing the vagal nerve). The pouch was totally separated from the main stomach, which was left in the abdomen. A 70-cm long Roux limb was connected to the small gastric pouch. The small bowel continuity was maintained by an enteroenterostomy between the Roux limb and the earlier divided proximal jejunum. All procedures were done through a short upper-midline incision, under general anesthesia.
Methods
All participants were investigated in the morning after an overnight fast. No medication or smoking was allowed after midnight. After recordings of height and weight, blood pressure was measured by a calibrated mercury sphygmomanometer to the nearest mm Hg after at least 30 min of rest. The average of three recordings was used.
The brachial artery ultrasound technique
The brachial artery was assessed by external B-mode ultrasound imaging 2-3 cm above the elbow (Acuson, 7.0 MHz linear transducer, Acuson, Mountain View, CA, USA) according to the recommendations of the International Brachial Artery Task Force. 27 Depth and gain settings were optimized to identify the lumen to vessel wall interface. The subject rested in the supine position for at least 30 min before the first scan and remained supine during the evaluation. Blood flow increase was induced by inflation of a pneumatic cuff placed around the forearm to a pressure at least 50 mm Hg above systolic blood pressure. When the cuff was rapidly deflated 5 min later, the artery was scanned continuously for 90 s and recorded on a Super VHS videotape for later analysis at the diameter. The diameter was manually measured at the peak of the R-wave at baseline and at 30, 60 and 90 s after cuff deflation. FMD was defined as the maximal brachial artery diameter recorded between 30 and 90 s after the cuff release minus diameter at rest divided by the diameter at rest and the ratio expressed as percentage.
We have previously shown the reproducibility (CV) to be 3% for baseline brachial artery diameter and 29% for FMD.
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Pulse-wave analysis A micromanometer-tipped probe (Sphygmocor, Pulse Wave Medical Ltd, Sydney, Australia) was applied to the surface of the skin overlying the radial artery, and the peripheral radial pulse wave was continuously recorded. The mean values of around 10 pulse waves were used for analyses. Recordings were regarded as satisfactory if the variations in the systolic peak and the diastolic peak were 5% or below. Only three attempts to achieve a satisfactory recording were allowed. The maximal systolic peak and the reflected waves were identified by the calculations of the first and second derivative of the pulse curve. After a baseline recording, terbutaline was subcutaneously administered (0.25 mg in the upper part of the arm) and a re-evaluation of the pulse wave was performed after 15 and 20 min. We have previously found that the maximal alterations in the pulse waveform occurred after 15 min in young healthy subjects. 16 Here, we performed a measurement also after 20 minutes in this 16 Here, we measured RI at baseline and after terbutaline and report the relative difference as the change in RI (%) from baseline after terbutaline. Thus, a large reduction of the RI wave indices indicates a good vasoreactive response. We have previously shown the reproducibility (CV) for the change in RI to be 9.4%. 16 
Blood analyses
Metabolic variables were determined with assays in routine use as described by Johansson et al. 28 The homeostasis model assessment (HOMA) index was determined by multiplying fasting plasma glucose (mmol l
À1
) and fasting serum insulin (mU l
) and then dividing by 22.5.
Statistics
Effects on the different variables over time were evaluated by analysis of variance for repeated measurements, using the Bonferroni correction for the post-hoc analysis for differences between 1-month and 1-year data compared with the baseline data. Fractional analysis of variance was used to compare baseline data in the surgery group with those in the control group. Linear regression was used to calculate relationship between changes in body weight or lipids vs changes in vasoreactivity. Two-tailed significance values were given with Po0.05 regarded as significant. The statistical program package StatView (SAS Inc, Cary, NC, USA) was used.
Results
Body weight was reduced from 126 ± 16 to 114 ± 14 kg 1 month after GBP surgery, and further to 90 ± 14 kg at 1 year. Corresponding changes in BMI were from 43.8±3.1 to 40.0 ± 3.1 kg m À2 and 31.1 ± 3.9 kg m
À2
, respectively. Blood pressure was not significantly different in the patients vs controls before surgery and did not change following the weight loss after GBP surgery. Neither heart rate was significantly different in the patients vs controls before GBP surgery, but a significant reduction was induced by treatment, being evident already after 1 month following GBP surgery (see Table 2 for details).
Before GBP surgery, the obese group showed a reduced vasodilation in resistance vessels, as measured by terbutaline-induced change in RI (18 ± 12 vs 37 ± 15% in controls, P ¼ 0.0001), but not significantly regarding FMD (7.9 ± 6.4 vs 8.9±5.4%), determined in the brachial artery. Change in RI improved in both men and women (Figure 1) , to 36 ± 12% at 1 month and to 44 ± 11% at 12 months (P ¼ 0.0001 vs baseline at 1 month and P ¼ 0.014 for 1 month vs 1 year, Figure 2 ), corresponding to measurements obtained in controls. No such corresponding significant improvement for FMD was seen (Figure 3 No significant correlation between the change in body weight induced by GBP surgery and the change in RI was seen at 1 month or 1 year. The change in RI was furthermore not related to the changes in variables of glucose and lipid metabolism, that is, glucose, insulin, HOMA, high-density lipoprotein-cholesterol, low-density lipoprotein-cholesterol, free fatty acids and serum triglycerides. The correlation between changes in RI and in heart rate at 1 month and 1 year (r ¼ À0.18 and À0.4, respectively) did not reach statistical significance.
Discussion
This study showed vasoreactivity in resistance vessels to be markedly reduced in obese subjects, but normalized already GBP surgery and vasoreactivity L Lind et al 1 month after GBP surgery, compared with a group of normal weight, matched controls. Vasoreactivity in the brachial conduit artery was not reduced in the obese and did not significantly change after GBP surgery.
Vasoreactivity in resistance vessels b-2 Receptor agonists, such as terbutaline or salbutamol, have been shown to induce vasodilation in resistance vessels when given locally in the forearm. When given systemically, such as in this study, terbutaline induces a marked reduction in the amplitude of the reflected waves visible at pulse-wave analysis. This reduction could be blunted by the nitric oxide synthase blocker NG-monomethyl L-arginine (L-NMMA), [14] [15] [16] suggesting this response to be endothelium-dependent. The pulse-wave response to terbutaline is furthermore related to the increase in forearm blood flow induced by locally given acetylcholine, 12,13 a marker of vasoreactivity in forearm resistance vessels. Thus, although not that widely spread as other techniques to study endothelial function, this pulse-wave-based technique is a valid technology for the study of resistance vessel vasoreactivity and, indeed, is related to coronary risk. 13 Using the pulse-wave-based technique, it has previously been shown that resistance vessel vasoreactivity is related to obesity. 13, 29, 30 Using either direct measurements of the visceral adipose tissue, 29, 30 or indirect measures, such as waist circumference, 31 has shown the pulse-wave response to be related mainly to the visceral type of fat. On the basis of regression analysis in the control group and in other cohorts, the reduction in body weight seen 1 month after bariatric surgery (9%) would only correspond to an improvement of 5% in resistance vessel vasoreactivity, 13 compared with the marked improvement seen in this study 1 month after surgery (a 75% increase). Thus, it is evident that other mechanisms than the weight loss itself are involved in the rapid normalization in resistance vessel reactivity.
Visceral type of fat is mobilized most rapidly after bariatric surgery, 28 a fact that might explain the rapid normalization in resistance vessel reactivity in this study despite that the subjects were still markedly overweight. It has also been reported by Park and Shim 17 that the improvement in the pulse-wave response after weight loss was proportional to the amount of loss in visceral fat, further emphasizing the important role of visceral adiposity in the determination of vasoreactivity. This study was not designed to study which link between visceral obesity and vasoreactivity could explain the rapid improvement in resistance vessel reactivity after surgery. Several alterations in adipocyte-generated substances could be acting in this setting, such as alterations in lipids, GBP surgery and vasoreactivity L Lind et al cytokines and adipokines, as well as glucometabolic variables. However, we could not show that the improvement in resistance vessel reactivity was related to the changes in lipids or glucometabolic variables. Another consequence of weight loss is a reduction in sympathetic nervous tone. 32 In this study, a reduction in heart rate was seen already 1 month after surgery, indicating an early reduction in sympathetic nervous tone. We have previously shown that an increase in a sympathetic activity induced by mental stress is rapidly followed by a reduction in resistance vessel endothelial function, 33 an action being mediated by b-adrenergic receptors. 34 Thus, a reduction in the sympathetic nervous activity might be yet another factor that could improve vasoreactivity in resistance vessels after weight loss, but we could not show that improvement in resistance vessel reactivity was closely related to the change in heart rate, a possible marker of sympathetic tone in this study.
Vasoreactivity in conduit artery
Although Williams and co-workers were able to show an improvement in FMD in eight morbidly obese subjects after bariatric surgery, we could not reproduce that finding. The most likely reason for an absence of improvement was that FMD at baseline was not significantly reduced in our patients. In the study by William et al., 23 FMD was reduced by 45% when the patients were compared to lean subjects. In that study, the patients with obesity were more overweight than in this study (BMI 52.2 vs 43.8 kg m À2 in our study), a difference that might explain the divergent results. As abdominal obesity is a major determinant also for FMD, 35 such a difference in abdominal fat would make a major difference between our samples. Raitakari et al. 36 showed an improvement in FMD in less-obese subjects (BMI 35.2 kg m
À2
) following weight reduction induced by a verylow-caloric diet, whereas this could not be seen in another study following weight reduction because of changes in lifestyle in obese subjects. 37 Thus, the response of FMD to weight loss seems to be different in different settings. Some studies, including this study, might have been underpowered to show significant effects of weight loss due to a rather high CV for FMD. We do not, however, think this is the reason for the lack of effect on FMD in this study, given the prominent effect on the pulse-wave-based technique. A reduction in resting brachial artery diameter was obtained after surgery. This might be to a reduced metabolic demand in the less-obese subjects and/or to a reduction in sympathetic nervous activity. As the resting brachial artery diameter is inversely related to FMD, 27 this might have induced the minor nonsignificant increase in FMD as seen in Figure 2 .
Limitations of the study An obvious limitation is the lack of a test of endotheliumindependent vasodilation. Therefore, we cannot conclude if the improvement in resistance vessel reactivity is endothelium-dependent or not. Another limitation is the lack of repeated measurements over time in the control group. It seems, however, unlikely that the dramatic improvement in resistance vessel vasoreactivity noted in this study would merely be due to a drift in the equipment, as no such tendency was noted in other studies taken place in parallel at our laboratory.
In conclusion, obese subjects showed a marked impairment in vasoreactivity in resistance, but not conduit, arteries that was normalized already 1 month after GBP surgery and consistently stable 1 year after surgery. The reduction in vasoreactivity was not related to changes in body weight or metabolic variables, suggesting a role of other mechanisms, such as changes in sympathetic nerve balance.
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